Search

Search any products, services and so on here.

About 16311 result(s)

Global Linagliptin Tablets Market Research Report 2024

  • Sep 18, 24
  • ID: 553594
  • Pages: 101
  • Figures: 99
  • Views: 0
  • From $2,900

Linagliptin tablets are a medication used to manage type 2 diabetes mellitus. Linagliptin is a DPP-4 (dipeptidyl peptidase-4) inhibitor, which works by increasing the levels of incretin hormones in the body. The global Linagliptin Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030. North Ameri...


Global Tofacitinib Citrate Drugs Market Research Report 2024

  • Sep 18, 24
  • ID: 553593
  • Pages: 114
  • Figures: 114
  • Views: 0
  • From $2,900

Tofacitinib citrate is a medication used to treat autoimmune diseases, primarily rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It is an oral Janus kinase (JAK) inhibitor that works by interfering with the JAK pathways involved in the immune response and inflammation. The global Tofacitinib Citrate Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ m...


Global Pomalidomide Capsules Market Research Report 2024

  • Sep 18, 24
  • ID: 553592
  • Pages: 80
  • Figures: 85
  • Views: 0
  • From $2,900

Pomalidomide capsules are an oral medication used to treat multiple myeloma. Pomalidomide is an immunomodulatory agent that works by modifying the immune system, inhibiting the growth of these cells, and disrupting their ability to form new blood vessels. The global Pomalidomide Capsules market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of...


Global Lacosamide Drugs Market Research Report 2024

  • Sep 18, 24
  • ID: 553591
  • Pages: 104
  • Figures: 103
  • Views: 0
  • From $2,900

Lacosamide is an anticonvulsant medication used to manage certain types of seizures in epilepsy.Lacosamide works by stabilizing hyperexcitable neuronal membranes and modulating the activity of sodium channels, which helps to prevent the excessive electrical activity in the brain that leads to seizures. It is typically taken in the form of tablets or oral solution. The global Lacosamide Drugs marke...


Global Nilotinib Generics Market Research Report 2024

  • Sep 18, 24
  • ID: 553590
  • Pages: 79
  • Figures: 80
  • Views: 0
  • From $2,900

Nilotinib generics are medications that contain nilotinib as the active ingredient, similar to the brand-name drug. Nilotinib is used to treat chronic myeloid leukemia (CML), particularly in patients with the Philadelphia chromosome-positive type. The global Nilotinib Generics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the...


Global Lisdexamfetamine Dimesylate Generics Market Research Report 2024

  • Sep 18, 24
  • ID: 553589
  • Pages: 91
  • Figures: 95
  • Views: 0
  • From $2,900

Lisdexamfetamine dimesylate generics are medications that contain the same active ingredient, lisdexamfetamine, as the brand-name drug. These generics are used to treat attention deficit hyperactivity disorder (ADHD) and moderate to severe binge eating disorder. The global Lisdexamfetamine Dimesylate Generics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030,...


Global OTC Eyedrop Market Research Report 2024

  • Sep 18, 24
  • ID: 537954
  • Pages: 88
  • Figures: 97
  • Views: 0
  • From $2,900

OTC (over-the-counter) eyedrops are non-prescription eye solutions used to relieve various common eye issues such as dryness, redness, itching, and irritation. These drops are readily available without the need for a doctor’s prescription and often used for temporary relief of symptoms caused by allergies, environmental factors, or prolonged screen use. OTC eyedrops come in different types, includ...


Global Lisdexamfetamine Dimesylate Capsules Market Research Report 2024

  • Sep 18, 24
  • ID: 553577
  • Pages: 96
  • Figures: 92
  • Views: 0
  • From $2,900

Lisdexamfetamine dimesylate capsules are a prescription medication primarily used to treat attention deficit hyperactivity disorder (ADHD) and, in some cases, moderate to severe binge eating disorder. The global Lisdexamfetamine Dimesylate Capsules market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030. N...


Global Olaparib Tablets Market Research Report 2024

  • Sep 18, 24
  • ID: 553576
  • Pages: 94
  • Figures: 97
  • Views: 0
  • From $2,900

Olaparib tablets are a PARP (poly ADP-ribose polymerase) inhibitor used to treat cancers associated with specific genetic mutations, particularly those involving BRCA1 or BRCA2 genes. The global Olaparib Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030. North American market for Olaparib Tab...


Global Fidaxomicin Drugs Market Research Report 2024

  • Sep 18, 24
  • ID: 553575
  • Pages: 73
  • Figures: 72
  • Views: 0
  • From $2,900

Fidaxomicin is an antibiotic used to treat Clostridium difficile infections, which belongs to the macrolide class of antibiotics and works by inhibiting bacterial RNA polymerase. The global Fidaxomicin Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030. North American market for Fidaxomicin Drug...


Our team would be happy to assist you with your queries.

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232